By rray, 26 January, 2024 Benefit of surgical LAA exclusion in absence of anticoagulation and risk of stroke systemic embolism is uncertain
By rray, 26 January, 2024 If CHA2DS2 VASc 2 w contraindications to oral anticoagulation or high risk of major bleeding percutaneous LAAO is reasonable option
By rray, 26 January, 2024 Either electrical or pharmacological cardioversion is acceptable safe and effective Electrical cardioversion is more effective but involves risk of anesthesia sedation
By rray, 25 January, 2024 Ongoing monitoring required nbsp nbsp amiodarone TSH AST ALT q3 6mo ECG q1y CXR and physical exam for visual abnormalities skin changes neuro sx annually nbsp nbsp dofetilide ECG K Mg CrCl q3 6mo nbsp nbsp dronedarone ECG AST ALT w in first 6mo nbsp nbsp
By rray, 25 January, 2024 If prior MI structural heart dz amiodarone dofetilide 1st line Sotalol 2nd line Flecainide and propafenone contraindicated
By rray, 25 January, 2024 Sotalol 3rd line option if no bradycardia Initiate as inpt for 3 day monitoring
By rray, 25 January, 2024 If no prolonged QT hypokalemia hypomagnesemia dofetilide is 1st line option w close monitor of QT K Mg and kidney function Initiate as inpt for 3 day monitoring